Ankyrin-B p.S646F undergoes increased proteasome degradation and reduces cell viability in the H9c2 rat ventricular cardiomyoblast cell line
Biochemistry and Cell Biology · 2020-04 · 98 (2) · 299-306
DOI: 10.1139/bcb-2019-0082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2020-04. Verfasst von Lena Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Divison of Medical Sciences, University of Victoria, Victoria, BC, Canada. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: CIHR.
Abstract (Originalsprache)
Ankyrin-B (AnkB) is scaffolding protein that anchors integral membrane proteins to the cardiomyocyte cytoskeleton. We recently identified an AnkB variant, AnkB p.S646F (ANK2 c.1937 C>T) associated with a phenotype ranging from predisposition for cardiac arrhythmia to cardiomyopathy. AnkB p.S646F exhibited reduced expression levels in the H9c2 rat ventricular-derived cardiomyoblast cell line relative to wildtype AnkB. Here, we demonstrate that AnkB is regulated by proteasomal degradation and proteasome inhibition rescues AnkB p.S646F expression levels in H9c2 cells, although this effect is not conserved with differentiation. We also compared the impact of wildtype AnkB and AnkB p.S646F on cell viability and proliferation. AnkB p.S646F expression resulted in decreased cell viability at 30 h after transfection, whereas we observed a greater proportion of cycling, Ki67-positive cells at 48 h after transfection. Notably, the number of GFP-positive cells was low and was consistent between wildtype AnkB and AnkB p.S646F expressing cells, suggesting that AnkB and AnkB p.S646F affected paracrine communication between H9c2 cells differentially. This work reveals that AnkB levels are regulated by the proteasome and that AnkB p.S646F compromises cell viability. Together, these findings provide key new insights into the putative cellular and molecular mechanisms of AnkB-related cardiac disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Divison of Medical Sciences, University of Victoria, Victoria, BC, Canada.
- Island Medical Program, University of British Columbia, Victoria, BC, Canada.
- Department of Medical Genetics, University of British Columbia, Victoria, BC, Canada.
Förderung
- CIHR
Zitieren
APA
Chen, L., Choi, C. S. W., Sanchez-Arias, J. C., Arbour, L. T., & Swayne, L. A. (2020). Ankyrin-B p.S646F undergoes increased proteasome degradation and reduces cell viability in the H9c2 rat ventricular cardiomyoblast cell line. Biochemistry and Cell Biology, 98(2), 299-306. https://doi.org/10.1139/bcb-2019-0082
Vancouver
Chen L, Choi CSW, Sanchez-Arias JC, Arbour LT, Swayne LA. Ankyrin-B p.S646F undergoes increased proteasome degradation and reduces cell viability in the H9c2 rat ventricular cardiomyoblast cell line. Biochemistry and Cell Biology. 2020;98(2):299-306. doi:10.1139/bcb-2019-0082
BibTeX
@article{Chen2020,
author = {Chen, Lena and Choi, Catherine S W and Sanchez-Arias, Juan C and Arbour, Laura T and Swayne, Leigh Anne},
title = {Ankyrin-B p.S646F undergoes increased proteasome degradation and reduces cell viability in the H9c2 rat ventricular cardiomyoblast cell line},
journal = {Biochemistry and Cell Biology},
year = {2020},
volume = {98},
number = {2},
pages = {299--306},
doi = {10.1139/bcb-2019-0082}
}
EUVIMED